英文名稱(chēng) | Siplizumab |
---|---|
中文名稱(chēng) | 西利珠單抗 |
CAS號(hào) | 288392-69-8 |
儲(chǔ)存條件 | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專(zhuān)享價(jià) | 數(shù)量 |
---|---|---|---|---|
1 mg | 3-5days | ¥3500.00 | 登錄后可見(jiàn) | |
5 mg | 3-5days | ¥15800.00 | 登錄后可見(jiàn) | |
10 mg | 3-5days | ¥28600.00 | 登錄后可見(jiàn) | |
50 mg | 3-5days | ¥128000.00 | 登錄后可見(jiàn) | |
100 mg | 3-5days | ¥236000.00 | 登錄后可見(jiàn) |
英文名稱(chēng) | Siplizumab |
---|---|
中文名稱(chēng) | 西利珠單抗 |
CAS號(hào) | 288392-69-8 |
儲(chǔ)存條件 | Sealed and stored at ≤-20℃, away from light. Avoid freeze-thaw cycles |
Siplizumab (Anti-CD2) is a humanized IgG1 monoclonal antibody targeting CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches na?ve and bona fide regulatory T cells. MW:145.5 KD.